Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.

Facchinetti, Fabrizio; Civelli, Maurizio; Singh, Dave; Papi, Alberto; Emirova, Aida; Govoni, Mirco

Facchinetti, Fabrizio; Civelli, Maurizio; Singh, Dave; Papi, Alberto; Emirova, Aida; Govoni, Mirco.

Afiliação

Facchinetti F; Corporate Pre-clinical R&D, Chiesi, Parma, Italy.
Civelli M; Corporate Pre-clinical R&D, Chiesi, Parma, Italy.
Singh D; Medicines Evaluation Unit, Manchester University NHS Foundation Hospital Trust, Manchester, United Kingdom.
Papi A; Respiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Emirova A; Global Clinical Development, Chiesi, Parma, Italy.
Govoni M; Global Clinical Development, Chiesi, Parma, Italy.

Front Pharmacol ; 12: 740803, 2021.

Article em En | MEDLINE | ID: mdl-34887752

Palavras-chave

COPDchronic obstructive pulmonary disease; asthma; inflammation; inhaled administration; phosphodiesterase 4 inhibitors (PDE4i)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália